Poob Semaglutide CAS 910463-68-2
Kev piav qhia
Semaglutide (910463-68-2) yog cov tshuaj tiv thaiv kab mob ntshav qab zib uas muag hauv cov npe xws li Ozempic, Wegovy, thiab Rybelsus.Nws yog siv los kho mob ntshav qab zib hom 2 thiab tswj qhov hnyav hnyav.Cov tshuaj ua haujlwm zoo ib yam li tib neeg glucagon-zoo li peptide-1 (GLP-1) los ntawm kev nce cov tshuaj insulin, uas ua rau kev txhim kho cov piam thaj metabolism.Nws yog muab faib ua metered subcutaneous txhaj tshuaj nyob rau hauv ib tug prefilled cwj mem, los yog raws li ib tug qhov ncauj daim ntawv.Ib qho ntawm nws qhov zoo dua lwm cov tshuaj tiv thaiv kab mob ntshav qab zib yog tias nws muaj lub sijhawm ntev ntawm kev ua, yog li, tsuas yog txhaj tshuaj ib zaug ib lub lim tiam yog txaus.
Siv
Semaglutide yog siv los tswj kev mob ntshav qab zib hom 2 nrog rau kev hloov hauv kev ua neej, xws li kev txwv kev noj zaub mov thiab ua kom lub cev muaj zog.Nws kuj tseem ua haujlwm los ntawm kev ua kom qeeb ntawm cov zaub mov los ntawm lub plab thiab tuaj yeem txo qis qab los noj mov thiab ua rau poob phaus.Tsis muaj cov ntaub ntawv tshaj tawm txog kev mob hepatotoxicity los ntawm kev kho semaglutide.
Mechanism ntawm kev ua
Semaglutide yog glucagon zoo li peptide-1 receptor agonist.Nws txhawb kev tsim cov tshuaj insulin, ib qho tshuaj hormones uas txo cov ntshav qab zib.Nws kuj tshwm sim los txhim kho kev loj hlob ntawm β hlwb hauv pancreas, uas yog qhov chaw ntawm cov tshuaj insulin.Nws kuj tseem inhibit glucagon, uas yog cov tshuaj hormones uas nce ntshav qab zib.Nws kuj tseem txo cov zaub mov kom tsawg los ntawm kev txo qis qab los noj mov thiab ua kom qeeb digestion hauv plab.Ua li no nws txo lub cev rog.
Kev ua lom lom
Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), ua haujlwm ntev glucagon-zoo li peptide 1 (GLP-1) analogue, yog GLP-1 receptor agonist nrog lub peev xwm rau kev kho mob ntawm hom 2 mob ntshav qab zib mellitus. (T2DM).
Ntim & Xa
